Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Phenotype of haptoglobin and presence of subclinical vascular disease: Population study.

Mostaza JM, de Dios O, Lahoz C, Arribas M, Pérez Arroyo A, Salinero-Fort MA, Laguna F, Estirado E, García-Iglesias F, González Alegre T, Sabín C, López S, Sánchez V, Cornejo V, Garcés C; en representación de los investigadores del estudio ESPREDIA.

Clin Investig Arterioscler. 2019 Jun 17. pii: S0214-9168(19)30050-6. doi: 10.1016/j.arteri.2019.03.007. [Epub ahead of print] English, Spanish.

PMID:
31221534
2.

R46L polymorphism in the PCSK9 gene: Relationship to lipid levels, subclinical vascular disease, and erectile dysfunction.

Mostaza JM, Lahoz C, Salinero-Fort MA, de Dios O, Castillo E, González-Alegre T, García-Iglesias F, Estirado E, Laguna F, Sabín C, López S, Cornejo V, de Burgos C, Sanchez V, Garcés C; investigators of the SPREDIA-2 Group.

J Clin Lipidol. 2018 Jul - Aug;12(4):1039-1046.e3. doi: 10.1016/j.jacl.2018.04.004. Epub 2018 Apr 21.

PMID:
29773421
3.

Relationship of the Adherence to a Mediterranean Diet and Its Main Components with CRP Levels in the Spanish Population.

Lahoz C, Castillo E, Mostaza JM, de Dios O, Salinero-Fort MA, González-Alegre T, García-Iglesias F, Estirado E, Laguna F, Sanchez V, Sabín C, López S, Cornejo V, de Burgos C, Garcés C; Investigators of the SPREDIA-2 Group.

Nutrients. 2018 Mar 20;10(3). pii: E379. doi: 10.3390/nu10030379.

4.

Prevalence of peripheral artery disease (PAD) and factors associated: An epidemiological analysis from the population-based Screening PRE-diabetes and type 2 DIAbetes (SPREDIA-2) study.

Cornejo Del Río V, Mostaza J, Lahoz C, Sánchez-Arroyo V, Sabín C, López S, Patrón P, Fernández-García P, Fernández-Puntero B, Vicent D, Montesano-Sánchez L, García-Iglesias F, González-Alegre T, Estirado E, Laguna F, de Burgos-Lunar C, Gómez-Campelo P, Abanades-Herranz JC, de Miguel-Yanes JM, Salinero-Fort MA; on behalf SPREDIA-2 Group.

PLoS One. 2017 Oct 26;12(10):e0186220. doi: 10.1371/journal.pone.0186220. eCollection 2017.

5.

Risk factors associated with the carotid intima-media thickness and plaques: ESPREDIA Study.

Mostaza JM, Lahoz C, Salinero-Fort MA, Laguna F, Estirado E, García-Iglesias F, González Alegre T, Sabín C, López S, Cornejo V; en representación de los investigadores del estudio ESPREDIA.

Clin Investig Arterioscler. 2018 Mar - Apr;30(2):49-55. doi: 10.1016/j.arteri.2017.07.005. Epub 2017 Sep 20. English, Spanish.

PMID:
28939054
6.

Modelling malaria incidence by an autoregressive distributed lag model with spatial component.

Laguna F, Grillet ME, León JR, Ludeña C.

Spat Spatiotemporal Epidemiol. 2017 Aug;22:27-37. doi: 10.1016/j.sste.2017.05.001. Epub 2017 Jun 8.

PMID:
28760265
7.

Effect of topical 1% cyclopentolate hydrochloride on tear production, pupil size, and intraocular pressure in healthy Beagles.

Costa D, Leiva M, Coyo N, Laguna F, Ríos J, Peña Gimenez MT.

Vet Ophthalmol. 2016 Nov;19(6):449-453. doi: 10.1111/vop.12323. Epub 2015 Oct 17.

PMID:
26475235
8.

Corneal grafting for the treatment of full-thickness corneal defects in dogs: a review of 50 cases.

Lacerda RP, Peña Gimenez MT, Laguna F, Costa D, Ríos J, Leiva M.

Vet Ophthalmol. 2017 May;20(3):222-231. doi: 10.1111/vop.12392. Epub 2016 May 31.

PMID:
27241238
9.

Peripheral Atherosclerosis in Patients With Erectile Dysfunction: A Population-Based Study.

Lahoz C, Mostaza JM, Salinero-Fort MA, García-Iglesias F, González-Alegre T, Estirado E, Laguna F, de Burgos-Lunar C, Sánchez-Arroyo V, Sabín C, López S, Cornejo-Del-Río V, Patrón P, Fernández-García P, Fernández-Puntero B, Vicent D, Montesano-Sanchez L; SPREDIA-2 Group.

J Sex Med. 2016 Jan;13(1):63-9. doi: 10.1016/j.jsxm.2015.11.011.

PMID:
26755088
10.

Carotid atherosclerosis severity in relation to glycemic status: a cross-sectional population study.

Mostaza JM, Lahoz C, Salinero-Fort MA, de Burgos-Lunar C, Laguna F, Estirado E, García-Iglesias F, González-Alegre T, Cornejo-Del-Río V, Sabín C, López S; SPREDIA-2 Group.

Atherosclerosis. 2015 Oct;242(2):377-82. doi: 10.1016/j.atherosclerosis.2015.07.028. Epub 2015 Jul 15.

PMID:
26275375
11.

Corneal grafting for the treatment of feline corneal sequestrum: a retrospective study of 18 eyes (13 cats).

Laguna F, Leiva M, Costa D, Lacerda R, Peña Gimenez T.

Vet Ophthalmol. 2015 Jul;18(4):291-6. doi: 10.1111/vop.12228. Epub 2014 Oct 22.

PMID:
25338923
12.

Metabolic syndrome in patients with peripheral arterial disease.

Estirado E, Lahoz C, Laguna F, García-Iglesias F, González-Alegre MT, Mostaza JM.

Rev Clin Esp. 2014 Nov;214(8):437-44. doi: 10.1016/j.rce.2014.05.005. Epub 2014 Jun 21. English, Spanish.

PMID:
24958317
13.

WITHDRAWN: The periodicity of Plasmodium vivax and Plasmodium falciparum in Venezuela.

Grillet ME, El Souki M, Laguna F, León JR.

Acta Trop. 2014 Feb;130:58-66. doi: 10.1016/j.actatropica.2013.10.010. Epub 2013 Oct 26. No abstract available. Retraction in: Acta Trop. 2014 Feb;130:R1.

PMID:
24463259
14.

The periodicity of Plasmodium vivax and Plasmodium falciparum in Venezuela.

Grillet ME, El Souki M, Laguna F, León JR.

Acta Trop. 2014 Jan;129:52-60. doi: 10.1016/j.actatropica.2013.10.007. Epub 2013 Oct 19.

PMID:
24149288
15.

[Clinical features of patients with hypertriglyceridemia referred to lipid units: registry of hypertrigliceridemia of the Spanish Arteriosclerosis Society].

Valdivielso P, Pintó X, Mateo-Gallego R, Masana L, Alvarez-Sala L, Jarauta E, Suárez M, García-Arias C, Plana N, Laguna F; Registro de HTG de la SEA.

Med Clin (Barc). 2011 Mar 12;136(6):231-8. doi: 10.1016/j.medcli.2010.09.028. Epub 2011 Jan 15. Spanish.

PMID:
21239026
16.

A prolonged, perplexing pyrexia.

Ruiz-Rivas JL, Val D, García F, Estirado E, Alonso MJ, Laguna F.

Am J Med. 2009 Nov;122(11):1001-3. doi: 10.1016/j.amjmed.2009.07.003. No abstract available.

PMID:
19854324
17.

[Carotid intima-media thickness in heterozygous familial hypercholesterolemia: associated factors and changes following 1 year of treatment].

Lahoz C, Mostaza JM, San Martín MA, García Iglesias MF, Frías M, García A, Peraira R, Laguna F; Nombre de los Investigadores del Estudio DISGEN Area.

Med Clin (Barc). 2009 Jun 27;133(4):121-6. doi: 10.1016/j.medcli.2009.02.052. Epub 2009 Jun 5. Spanish.

PMID:
19501375
18.

Data mining validation of fluconazole breakpoints established by the European Committee on Antimicrobial Susceptibility Testing.

Cuesta I, Bielza C, Larrañaga P, Cuenca-Estrella M, Laguna F, Rodriguez-Pardo D, Almirante B, Pahissa A, Rodríguez-Tudela JL.

Antimicrob Agents Chemother. 2009 Jul;53(7):2949-54. doi: 10.1128/AAC.00081-09. Epub 2009 May 11.

19.

Correlation of the MIC and dose/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia.

Rodríguez-Tudela JL, Almirante B, Rodríguez-Pardo D, Laguna F, Donnelly JP, Mouton JW, Pahissa A, Cuenca-Estrella M.

Antimicrob Agents Chemother. 2007 Oct;51(10):3599-604. Epub 2007 Jul 23.

20.

[Clinical factors associated with inappropriate prescription of statins].

Lahoz C, Vicente I, Criado A, Laguna F, Torrecilla E, Mostaza JM.

Med Clin (Barc). 2007 Jun 16;129(3):86-90. Spanish.

PMID:
17594857
21.

[Ankle-brachial index in patients with diabetes mellitus: prevalence and risk factors].

Vicente I, Lahoz C, Taboada M, Laguna F, García-Iglesias F, Mostaza Prieto JM.

Rev Clin Esp. 2006 May;206(5):225-9. Spanish.

PMID:
16750105
22.

Metabolic syndrome and asymptomatic peripheral artery disease in subjects over 60 years of age.

Lahoz C, Vicente I, Laguna F, García-Iglesias MF, Taboada M, Mostaza JM.

Diabetes Care. 2006 Jan;29(1):148-50. No abstract available.

PMID:
16373915
23.

The -514C/T polymorphism of the hepatic lipase gene significantly modulates the HDL-cholesterol response to statin treatment.

Lahoz C, Peña R, Mostaza JM, Laguna F, García-Iglesias MF, Taboada M, Pintó X; RAP Study Group.

Atherosclerosis. 2005 Sep;182(1):129-34. Epub 2005 Feb 26.

PMID:
16115483
25.

[Prevalence of an abnormal ankle-brachial index in relation to the cardiovascular risk estimated by the Framingham function].

Vicente I, Lahoz C, Taboada M, García A, San Martín MA, Terol I, Laguna F, García-Iglesias F, Mostaza JM.

Med Clin (Barc). 2005 May 7;124(17):641-4. Spanish.

PMID:
15882509
26.

[The application of the SCORE charts to advanced age males triple the number of high-risk subjects compared to the Framingham function].

Mostaza JM, Vicente I, Taboada M, Laguna F, Echániz A, García-Iglesias F, Lahoz C.

Med Clin (Barc). 2005 Apr 9;124(13):487-90. Spanish.

PMID:
15847765
27.

Prevention of opportunistic infections in adult and adolescent patients with HIV infection. GESIDA/National AIDS Plan guidelines, 2004 [correction].

Berenguer J, Laguna F, López-Aldeguer J, Moreno S, Arribas JR, Arrizabalaga J, Baraia J, Casado JL, Cosín J, Polo R, González-García J, Iribarren JA, Kindelán JM, López-Bernaldo de Quirós JC, López-Vélez R, Lorenzo JF, Lozano F, Mallolas J, Miró JM, Pulido F, Ribera E.

Enferm Infecc Microbiol Clin. 2004 Mar;22(3):160-76. Review. English, Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2004 Nov;22(5):271.

PMID:
14987537
28.

Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients.

López-Vélez R, Videla S, Márquez M, Boix V, Jiménez-Mejías ME, Górgolas M, Arribas JR, Salas A, Laguna F, Sust M, Cañavate C, Alvar J; Spanish HIV-Leishmania Study Group.

J Antimicrob Chemother. 2004 Mar;53(3):540-3. Epub 2004 Jan 22.

PMID:
14739148
29.

Treatment of leishmaniasis in HIV-positive patients.

Laguna F.

Ann Trop Med Parasitol. 2003 Oct;97 Suppl 1:135-42. Review.

PMID:
14678640
30.

Visceral leishmaniasis in those infected with HIV: clinical aspects and other opportunistic infections.

Russo R, Laguna F, López-Vélez R, Medrano FJ, Rosenthal E, Cacopardo B, Nigro L.

Ann Trop Med Parasitol. 2003 Oct;97 Suppl 1:99-105. Review.

PMID:
14678637
31.

Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study.

Laguna F, Videla S, Jiménez-Mejías ME, Sirera G, Torre-Cisneros J, Ribera E, Prados D, Clotet B, Sust M, López-Vélez R, Alvar J; Spanish HIV-Leishmania Study Group.

J Antimicrob Chemother. 2003 Sep;52(3):464-8. Epub 2003 Jul 29.

PMID:
12888588
32.

Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy.

Berenguer J, Miralles P, Arrizabalaga J, Ribera E, Dronda F, Baraia-Etxaburu J, Domingo P, Márquez M, Rodriguez-Arrondo FJ, Laguna F, Rubio R, Lacruz Rodrigo J, Mallolas J, de Miguel V; GESIDA 11/99 Study Group.

Clin Infect Dis. 2003 Apr 15;36(8):1047-52. Epub 2003 Apr 2.

PMID:
12684918
33.

[Recommendations of the Spanish AIDS Study Group (GESIDA) and the National Aids Plan (PNS) for antiretroviral treatment in adult patients with human immunodeficiency virus infection in 2002].

Rubio R, Berenguer J, Miró JM, Antela A, Iribarren JA, González J, Guerra L, Moreno S, Arrizabalaga J, Clotet B, Gatell JM, Laguna F, Martínez E, Parras F, Santamaría JM, Tuset M, Viciana P.

Enferm Infecc Microbiol Clin. 2002 Jun-Jul;20(6):244-303. Review. Spanish.

PMID:
12084354
34.

A nested polymerase chain reaction (Ln-PCR) for diagnosing and monitoring Leishmania infantum infection in patients co-infected with human immunodeficiency virus.

Cruz I, Cañavate C, Rubio JM, Morales MA, Chicharro C, Laguna F, Jiménez-Mejías M, Sirera G, Videla S, Alvar J; Spanish HIV-Leishmania Study Group.

Trans R Soc Trop Med Hyg. 2002 Apr;96 Suppl 1:S185-9.

PMID:
12055836
35.

Relapses versus reinfections in patients coinfected with Leishmania infantum and human immunodeficiency virus type 1.

Morales MA, Cruz I, Rubio JM, Chicharro C, Cañavate C, Laguna F, Alvar J.

J Infect Dis. 2002 May 15;185(10):1533-7. Epub 2002 Apr 22.

PMID:
11992294
36.

[Gastrointestinal infection caused by Mycobacterium avium complex in patients with AIDS].

Carbó J, Laguna F, Muñoz F, March J, Iñiguez A, Alvarez I, Casado I, García-Samaniego J.

Rev Esp Enferm Dig. 2001 Sep;93(9):612-4. Spanish. No abstract available.

PMID:
11767442
37.

[Multiresistant tuberculosis caused by Mycobacterium bovis and human immunodeficiency virus infection. Are there new therapeutic possibilities?].

Valencia ME, Moreno V, Laguna F, González-Lahoz JM.

Enferm Infecc Microbiol Clin. 2001 Jan;19(1):37-9. Spanish. No abstract available.

PMID:
11256251
38.

[Recommendations of GESIDA (Grupo de Estudio de SIDA)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (II)].

Miró JM, Antela A, Arrizabalaga J, Clotet B, Gatell JM, Guerra L, Antonio Iribarren J, Laguna F, Moreno S, Parras F, Rubio R, Santamaría JM, Viciana P; Grupo de Estudio de SIDA (GESIDA) y por Consejo Asesor Clínico (CAC) de la Secretaría Plan Naciona.

Enferm Infecc Microbiol Clin. 2000 Oct;18(8):396-412. Spanish.

PMID:
11153204
40.

[Recommendation of GESIDA (AIDS Study Group)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (I)].

Miró JM, Antela A, Arrizabalaga J, Clotet B, Gatell JM, Guerra L, Iribarren JA, Laguna F, Moreno S, Parras F, Rubio R, Santamaría JM, Viciana P.

Enferm Infecc Microbiol Clin. 2000 Aug-Sep;18(7):329-51. Spanish.

PMID:
11109725
41.

HIV--Leishmania infantum co-infection: humoral and cellular immune responses to the parasite after chemotherapy.

Moreno J, Cañavate C, Chamizo C, Laguna F, Alvar J.

Trans R Soc Trop Med Hyg. 2000 May-Jun;94(3):328-32.

PMID:
10975014
42.

Diagnostic utility of a multiplex herpesvirus PCR assay performed with cerebrospinal fluid from human immunodeficiency virus-infected patients with neurological disorders.

Quereda C, Corral I, Laguna F, Valencia ME, Tenorio A, Echeverria JE, Navas E, Martín-Dávila P, Moreno A, Moreno V, Gonzalez-Lahoz JM, Arribas JR, Guerrero A.

J Clin Microbiol. 2000 Aug;38(8):3061-7.

43.

[Nephrotic syndrome and acute pancreatitis related to glucantime administration].

Valencia ME, Laguna F, González Lahoz J.

An Med Interna. 2000 Jan;17(1):54. Spanish. No abstract available.

PMID:
10730416
44.

[The recommendations of GESIDA/SEFH/PNS for improving adherence to antiretroviral treatment. AIDS Study Group of the Spanish Society of Hospital Pharmacy and the National Plan on AIDS of the Minister of Health and Consumers].

Knobel H, Codina C, Miró JM, Carmona A, García B, Antela A, Gómez-Domingo MR, Arrizabalaga J, Iruin A, Laguna F, Jiménez I, Rubio R, Lluch A, Viciana P.

Enferm Infecc Microbiol Clin. 2000 Jan;18(1):27-39. Spanish.

PMID:
10721560
45.

AIDS-related body cavity-based lymphomas, herpesvirus-8 and HIV infection: a study of seven cases.

Valencia ME, Martinez P, Moreno V, Laguna F, Lahoz JG.

AIDS. 1999 Dec 24;13(18):2603-5. No abstract available.

PMID:
10630536
46.

Molecular characterization by PCR-fingerprinting of Candida dubliniensis strains isolated from two HIV-positive patients in Spain.

Diaz-Guerra TM, Mellado E, Cuenca Estrella M, Laguna F, Rodriguez-Tudela JL.

Diagn Microbiol Infect Dis. 1999 Oct;35(2):113-9.

PMID:
10579091
47.

Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. Spanish HIV-Leishmania Study Group.

Laguna F, López-Vélez R, Pulido F, Salas A, Torre-Cisneros J, Torres E, Medrano FJ, Sanz J, Picó G, Gómez-Rodrigo J, Pasquau J, Alvar J.

AIDS. 1999 Jun 18;13(9):1063-9.

PMID:
10397536
48.

Infection of sand flies by humans coinfected with Leishmania infantum and human immunodeficiency virus.

Molina R, Lohse JM, Pulido F, Laguna F, López-Vélez R, Alvar J.

Am J Trop Med Hyg. 1999 Jan;60(1):51-3.

PMID:
9988321
49.

[Recommendations for antiretroviral treatment in 1998. AIDS Working Group of the Spanish Society for Infectious Diseases and Clinical Microbiology (SEIMC)].

Moreno S, Arrizabalaga J, Gatell JM, Clotet B, Aguirrebengoa K, Antela A, Iribarren JA, Laguna F, Miró JM, Ocaña I, Rubio R, Viciana P, Podzamczer D.

Enferm Infecc Microbiol Clin. 1998 Oct;16(8):374-6. Spanish. No abstract available.

PMID:
9835154
50.

Change in fluconazole susceptibility patterns and genetic relationship among oral Candida albicans isolates.

Diaz-Guerra TM, Martinez-Suarez JV, Laguna F, Valencia E, Rodriguez-Tudela JL.

AIDS. 1998 Sep 10;12(13):1601-10.

PMID:
9764778

Supplemental Content

Loading ...
Support Center